secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2026-09-18T20:05:16+00:00
Accession:  0001193125-26-395511
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics closes $0.5M private placement with CSO; shareholders approve warrant issuance
--------------------------------------------------------------------------------

- CSO Hamid Khoja purchased 298,508 shares plus warrants at $1.675 combined price ($1.55 stock + $0.125 warrant) on Sept 15, 2026.
- Gross proceeds ~$0.5M; net proceeds to be used for general corporate purposes and working capital.
- Warrants exercisable at $1.55, immediately exercisable, expire in 5 years from issuance.
- Shareholders approved issuance of up to 8,448,980 shares (8,163,266 + 285,714) upon warrant exercise; votes: 3,153,098 for, 258,217 against.
- Special meeting held Sept 17, 2026; 3,431,761 shares represented out of 8,283,193 entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526395511/0001193125-26-395511-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000119312526395511/fblg-20260917.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-395511

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer